These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33668216)

  • 21. Detection of equine herpesvirus-specific effector and memory cytotoxic immunity in the equine upper respiratory tract.
    Breathnach CC; Yeargan MR; Timoney JF; Allen GP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):117-25. PubMed ID: 16472871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Equine herpesvirus type-1 modulates CCL2, CCL3, CCL5, CXCL9, and CXCL10 chemokine expression.
    Wimer CL; Damiani A; Osterrieder N; Wagner B
    Vet Immunol Immunopathol; 2011 Apr; 140(3-4):266-74. PubMed ID: 21349590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Equine herpesvirus 1 myeloencephalopathy.
    Pusterla N; Hussey GS
    Vet Clin North Am Equine Pract; 2014 Dec; 30(3):489-506. PubMed ID: 25300635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case-control study of a multistate equine herpesvirus myeloencephalopathy outbreak.
    Traub-Dargatz JL; Pelzel-McCluskey AM; Creekmore LH; Geiser-Novotny S; Kasari TR; Wiedenheft AM; Bush EJ; Bjork KE
    J Vet Intern Med; 2013; 27(2):339-46. PubMed ID: 23398291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide association study of equine herpesvirus type 1-induced myeloencephalopathy identifies a significant single nucleotide polymorphism in a platelet-related gene.
    Brosnahan MM; Al Abri MA; Brooks SA; Antczak DF; Osterrieder N
    Vet J; 2019 Mar; 245():49-54. PubMed ID: 30819425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated immunity evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow cytometry.
    Platt R; Sponseller BA; Chiang YW; Roth JA
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):275-81. PubMed ID: 20116862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of viral antigens on the surface of equine herpesvirus-1-infected peripheral blood mononuclear cells: a strategy to avoid complement-mediated lysis.
    van der Meulen KM; Nauwynck HJ; Pensaert MB
    J Gen Virol; 2003 Jan; 84(Pt 1):93-97. PubMed ID: 12533704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of equid herpesvirus 1 for the veterinary practitioner. Part B: pathogenesis and epidemiology.
    Dunowska M
    N Z Vet J; 2014 Jul; 62(4):179-88. PubMed ID: 24597839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of viral envelope proteins in equine herpesvirus 1-infected blood mononuclear cells during cell-associated viremia.
    van der Meulen K; Caij B; Pensaert M; Nauwynck H
    Vet Microbiol; 2006 Mar; 113(3-4):265-73. PubMed ID: 16387454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review of equid herpesvirus 1 for the veterinary practitioner. Part A: clinical presentation, diagnosis and treatment.
    Dunowska M
    N Z Vet J; 2014 Jul; 62(4):171-8. PubMed ID: 24597778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-mediated cytolysis of equine herpesvirus-infected cells by leukocytes from young vaccinated horses.
    Ellis JA; Steeves E; Wright AK; Bogdan JR; Davis WC; Kanara EW; Haines DM
    Vet Immunol Immunopathol; 1997 Jul; 57(3-4):201-14. PubMed ID: 9261959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares.
    Kydd JH; Wattrang E; Hannant D
    Vet Immunol Immunopathol; 2003 Dec; 96(3-4):207-17. PubMed ID: 14592733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokine responses to EHV-1 infection in immune and non-immune ponies.
    Coombs DK; Patton T; Kohler AK; Soboll G; Breathnach C; Townsend HG; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):109-16. PubMed ID: 16473413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Equine herpesvirus-1 myeloencephalopathy: a review of recent developments.
    Pusterla N; David Wilson W; Madigan JE; Ferraro GL
    Vet J; 2009 Jun; 180(3):279-89. PubMed ID: 18805030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Equine herpesvirus-1 genotype did not significantly affect clinical signs and disease outcome in 65 horses diagnosed with equine herpesvirus-1 myeloencephalopathy.
    Pusterla N; Hatch K; Crossley B; Wademan C; Barnum S; Flynn K
    Vet J; 2020 Jan; 255():105407. PubMed ID: 31982080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification by real-time PCR of the magnitude and duration of leucocyte-associated viraemia in horses infected with neuropathogenic vs. non-neuropathogenic strains of EHV-1.
    Allen GP; Breathnach CC
    Equine Vet J; 2006 May; 38(3):252-7. PubMed ID: 16706281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Equine Herpesvirus 1 Bridles T Lymphocytes To Reach Its Target Organs.
    Poelaert KCK; Van Cleemput J; Laval K; Favoreel HW; Couck L; Van den Broeck W; Azab W; Nauwynck HJ
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First detection of the equine herpesvirus 1 neuropathogenic variant in Brazil.
    Mori E; Borges AS; Delfiol DJ; Oliveira Filho JP; Gonçalves RC; Cagnini DQ; Lara MC; Cunha EM; Villalobos EM; Nassar AF; Castro AM; Brandao PE; Richtzenhain LJ
    Rev Sci Tech; 2011 Dec; 30(3):949-54. PubMed ID: 22435205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenic potential of equine alphaherpesviruses: the importance of the mononuclear cell compartment in disease outcome.
    Osterrieder N; Van de Walle GR
    Vet Microbiol; 2010 Jun; 143(1):21-8. PubMed ID: 20202764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The deletion of the ORF1 and ORF71 genes reduces virulence of the neuropathogenic EHV-1 strain Ab4 without compromising host immunity in horses.
    Wimer CL; Schnabel CL; Perkins G; Babasyan S; Freer H; Stout AE; Rollins A; Osterrieder N; Goodman LB; Glaser A; Wagner B
    PLoS One; 2018; 13(11):e0206679. PubMed ID: 30440016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.